IBB vs SCHB

iShares Biotechnology ETF vs Schwab US Broad Market ETF

Quick take
  • SCHB has the lower expense ratio at 0.03% vs 0.44% for IBB.
  • SCHB pays a higher dividend yield (1.07%).

Side-by-side metrics

MetricIBBSCHB
Expense ratio
Annual fee. Lower is better.
0.44%0.03%
Dividend yield
Trailing 12-month yield.
0.23%1.07%
AUM
Assets under management — bigger funds are typically more liquid.
$7.95B$40.99B
YTD return
3.10%8.34%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.741.04
P/E ratio
23.7226.72
Last price
$170.10$28.21
Inception
Issuer
iSharesSchwab

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

SCHB top holdings

Top holdings · SCHB
NVDANVIDIA Corp7.38%
AAPLApple Inc5.76%
MSFTMicrosoft Corp4.58%
AMZNAmazon.com Inc3.73%
GOOGLAlphabet Inc Class A2.96%
AVGOBroadcom Inc2.79%
GOOGAlphabet Inc Class C2.36%
METAMeta Platforms Inc Class A2.12%
TSLATesla Inc1.52%
BRK-BBerkshire Hathaway Inc Class B1.27%
Sector breakdown · SCHB
Real Estate2.4%
Consumer Cyclical10.1%
Basic Materials2.0%
Consumer Defensive4.6%
Technology34.4%
Communication Services10.1%
Financial Services12.2%
Utilities2.3%
Industrials9.4%
Energy3.7%
Healthcare8.9%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About SCHB

SCHB (Schwab US Broad Market ETF) is Total US equity market. Managed by Schwab, the fund carries $41.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.07%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.4% of the portfolio. Real Estate is the fund's largest sector exposure at 2.4%.